ERBB2-Low Expression and Efficacy of CDK 4/6 Inhibitor in HR-Positive, ERBB2-Negative Breast Cancer Kelvin K. H. Bao, MB, BChir, MA1; Leone Sutanto, MB, ChB1; Shirley S. W. Tse, MB, BS1; et al 8-10 minutes November 5, 2021 The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in…
https://www.sciencedaily.com/releases/2022/01/2201... In normal cells, electrical voltage patterns provide a blueprint for orderly growth. But with cancer, the opposite happens. Marked by a breakdown in the normal electrical patterns generated by the cells, they lose their specialized functions, start expanding into a…
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer https://www.nature.com/articles/s41523-021-00319-4...